Harold J. Burstein, MD, PhD

Article

Key Abstracts in Early Breast Cancer From ASCO 2023

Author:: Harold J. Burstein, MD, PhD

Publish date: June 22, 2023

Dr Harold Burstein highlights abstracts in early breast cancer from ASCO 2023, including the NATALEE trial of CDK4/6 inhibitor ribociclib and a met...

Article

Top Studies in Metastatic Breast Cancer From SABCS 2022

Author:: Harold J. Burstein, MD, PhD

Publish date: December 27, 2022

Top studies in metastatic breast cancer from SABCS 2022 focus on practice-changing therapies for HR+/HER2- breast cancer, a follow-up of the monarc...

Article

Key Abstracts in Metastatic Breast Cancer From the 2022 American Society of Clinical Oncology Annual Meeting

Author:: Harold J. Burstein, MD, PhD

Publish date: June 29, 2022

Key abstracts in metastatic breast cancer from ASCO 2022 include "showstopper" results from DESTINY-Breast04 and benefit from sacituzumab govitecan...

Article

Key Studies in Early Breast Cancer From ASCO 2021

Author:: Harold J. Burstein, MD, PhD

Publish date: June 28, 2021

Dr. Harold Burstein highlights studies in early breast cancer from ASCO 2021, including adjuvant olaparib in HR+/HER2- disease, neoadjuvant therapy...